Gain Therapeutics, Inc. GANX
NASDAQ · United States · Health Technology
$1.71-0.01 (-0.58%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-11 | -0.11 | -0.14 | +20.3% | $0 | — | +19.8%$1.77→$2.12 |
| Q1 2026 | 2026-05-11 | -0.13 | -0.14 | +7.1% | — | — | -1.1%$1.82→$1.80 |
| Q4 2025 | 2026-03-26 | -0.11 | -0.14 | +21.4% | — | — | -6.6%$1.96→$1.83 |
| Q3 2025 | 2025-11-12 | -0.15 | -0.15 | 0.0% | — | — | +11.6%$2.68→$2.99 |
| Q2 2025 | 2025-08-12 | -0.19 | -0.17 | -11.8% | — | — | — |
| Q1 2025 | 2025-05-14 | -0.16 | -0.17 | +5.9% | — | — | — |
| Q4 2024 | 2025-03-27 | -0.08 | -0.19 | +57.9% | — | — | — |
| Q3 2024 | 2024-11-14 | -0.17 | -0.21 | +19.0% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.